Novo Nordisk

Zealand Pharma

This biotechnology company develops peptide-based medicines for patients with obesity, rare diseases and chronic inflammation through metabolic health research.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Lilly

This company manufactures pharmaceutical drugs and digital health tools for patients living with chronic conditions like diabetes, obesity, migraines and autoimmune diseases.

Eli Lilly

This pharmaceutical company develops and sells prescription medicines for patients with conditions including diabetes, obesity, cancer, immunology disorders and neurological diseases.

Genentech

This biotechnology company develops and manufactures medicines for patients with serious diseases including cancer, multiple sclerosis, and respiratory conditions.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

Regeneron

This biopharmaceutical company develops medicines for serious diseases, including eye conditions, cancer and inflammatory disorders, for healthcare providers and global patients.

Amgen Europe

This company develops and manufactures biotechnological medicines to treat patients with serious conditions such as cancer, cardiovascular disease and inflammatory disorders.